CSBR - Champions Oncology, Inc.
| Previous Close | 8.21 |
| Open | 7.86 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1100 |
| Day's Range | 7.84 - 8.51 |
| 52 Week Range | 4.98 - 12.80 |
| Volume | 39,219 |
| Avg. Volume | 57,411 |
| Market Cap | 98.888M |
| Beta (5Y Monthly) | 1.29 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 |
| Earnings Date | Mar 15, 2020 - Mar 19, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.67 |
- Zacks
How to Time the Markets Like an Investing Pro - January 17, 2020
In the long-run, does consistent market timing really matter to be a successful investor?
- Simply Wall St.
Is There An Opportunity With Champions Oncology, Inc.'s (NASDAQ:CSBR) 42% Undervaluation?
Does the January share price for Champions Oncology, Inc. (NASDAQ:CSBR) reflect what it's really worth? Today, we will...
- Zacks
The Market Timing Secrets No One Talks About - December 24, 2019
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
- ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $7.6 Million
Records Second Quarter Income of $291,000 HACKENSACK, NJ / ACCESSWIRE / December 16, 2019 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in an end-to-end range of research and development technology ...
- ACCESSWIRE
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 16, 2019
HACKENSACK, NJ / ACCESSWIRE / December 9, 2019 / Champions Oncology, Inc. (CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced it will report its financial and operational results for the second quarter ended October 31, 2019, on Monday, December 16, 2019, after market close. The company will host a conference call to discuss the results that day at 4:30 p.m. EST (1:30 p.m. PST). A replay of the call will be available by dialing 877-481-4010 and entering Passcode:56884, or by accessing the Investor tab of the company's website within 72 hours.
- Simply Wall St.
Investors Who Bought Champions Oncology (NASDAQ:CSBR) Shares Three Years Ago Are Now Up 231%
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
- Zacks
Simple Market Timing Strategies That Work - December 04, 2019
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
- Zacks
The Truth About Market Timing - November 14, 2019
In the long-run, does consistent market timing really matter to be a successful investor?
- ACCESSWIRE
Champions Oncology and PhenoVista Biosciences Announce a Strategic Partnership to provide Oncology Imaging-based Phenotypic Assays for Preclinical Drug Development
HACKENSACK, NJ / ACCESSWIRE / November 13, 2019 / Champions Oncology (NASDAQ:CSBR), an end-to-end R&D Oncology solutions company announced today that they have entered into a strategic partnership with ...
- Simply Wall St.
What Kind Of Shareholders Own Champions Oncology, Inc. (NASDAQ:CSBR)?
The big shareholder groups in Champions Oncology, Inc. (NASDAQ:CSBR) have power over the company. Institutions will...
- Zacks
The Truth About Market Timing - October 24, 2019
In the long-run, does consistent market timing really matter to be a successful investor?
- Simply Wall St.
We Think Champions Oncology (NASDAQ:CSBR) Can Easily Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
- Zacks
When Does Market Timing Actually Work? - October 03, 2019
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
- Simply Wall St.
What Does Champions Oncology, Inc.'s (NASDAQ:CSBR) Share Price Indicate?
Champions Oncology, Inc. (NASDAQ:CSBR), which is in the life sciences business, and is based in United States, saw...
- ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $6.7 Million
HACKENSACK, NJ / ACCESSWIRE / September 16, 2019 / Champions Oncology, Inc. (NASDAQ:CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development ...
- ACCESSWIRE
Champions Oncology, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / September 16, 2019 / Champions Oncology, Inc. (NASDAQ: CSBR ) will be discussing their earnings results in their 2020 First Quarter Earnings to be held on September 16, 2019 ...
- Zacks
The Truth About Market Timing - September 13, 2019
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
- ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Monday, September 16, 2019
HACKENSACK, NJ / ACCESSWIRE / September 9, 2019 / Champions Oncology, Inc. (CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced it will report its financial and operational results for the first quarter ended July 31, 2019, on Monday, September 16, 2019, after market close. The company will host a conference call to discuss the results that day at 4:30 p.m. EDT (1:30 p.m. PDT). A replay of the call will be available by dialing 877-481-4010 and entering Passcode:53656, or by accessing the Investor tab of the company's website within 72 hours.
- Simply Wall St.
How Much is Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Getting Paid?
Ronnie Morris has been the CEO of Champions Oncology, Inc. (NASDAQ:CSBR) since 2017. This report will, first, examine...
- Zacks
Yes, You Can Time the Market. Find out How - August 26, 2019
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
- Zacks
Simple Market Timing Strategies That Work - August 05, 2019
In the long-run, does consistent market timing really matter to be a successful investor?
- GuruFocus.com
Champions Oncology Inc (CSBR) Files 10-K for the Fiscal Year Ended on April 30, 2019
Champions Oncology Inc (CSBR) files its latest 10-K with SEC for the fiscal year ended on April 30, 2019. Continue reading...
- Simply Wall St.
Champions Oncology, Inc. (NASDAQ:CSBR) Delivered A Weaker ROE Than Its Industry
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
- ACCESSWIRE
Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019
Record Annual Revenue of $27 Million HACKENSACK, NJ / ACCESSWIRE / July 15, 2019 / Champions Oncology, Inc. (NASDAQ: CSBR), engaged in the development of advanced technology solutions and services to personalize ...
- ACCESSWIRE
Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 15, 2019
HACKENSACK, NJ / ACCESSWIRE / July 12, 2019 / Champions Oncology, Inc. (CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced it will report its financial and operational results for the fourth quarter ended April 30, 2019, on Monday, July 15, 2019, after market close. The company will host a conference call to discuss the results that day at 4:30 p.m. EST (1:30 p.m. PST). A replay of the call will be available by dialing 877-481-4010 and entering Passcode: 50412, or by accessing the Investor tab of the company's website within 72 hours.
